Journal of the American Pharmacists Association : JAPhA
-
J Am Pharm Assoc (2003) · May 2017
Randomized Controlled TrialPharmacist-to-prescriber intervention to close therapeutic gaps for statin use in patients with diabetes: A randomized controlled trial.
To assess the effect of a community pharmacist-led intervention on the proportion of patients with diabetes placed on statin therapy. ⋯ Through a brief pharmacist-to-provider intervention, a significant gap closure in statin therapy was seen in patients with diabetes. There is an opportunity for pharmacies, health plans, and prescribers to utilize the community pharmacist in achieving quality, evidence-based patient care.